31
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Phytochemical Screening, Antibacterial, Antifungal, Antiviral, Cytotoxic, and Anti-Quorum-Sensing Properties of Teucrium polium L. Aerial Parts Methanolic Extract

      research-article

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The chemical profile of Teucrium polium L. ( T. polium) methanolic extract was tested using liquid chromatography coupled with high resolution mass spectrometry (HR-LCMS). Disc diffusion and microdilution assays were used for the antimicrobial activities. Coxsackievirus B-3 (CVB3) and Herpes simplex virus type 2 (HSV-2) were used for the antiviral activities. Chromobacterium violaceum (ATCC 12472 and CV026) and Pseudomonas aeruginosa PAO1 were used as starter strains for the anti-quorum sensing tests. Isoprenoids are the main class of compounds identified, and 13R-hydroxy-9E,11Z-octadecadienoic acid, valtratum, rhoifolin, sericetin diacetate, and dihydrosamidin were the dominant phytoconstituents. The highest mean diameter of growth inhibition zone was recorded for Acinetobacter baumannii (19.33 ± 1.15 mm). The minimal inhibitory concentrations were ranging from 6.25 to 25 mg/mL for bacterial strains, and from 6.25 to 25 mg/mL for Candida species. The 50% cytotoxic concentration on VERO (African Green Monkey Kidney) cell lines was estimated at 209 µg/mL. No antiviral activity was recorded. Additionally, T. polium extract was able to inhibit P. aeruginosa PAO1 motility in a concentration-dependent manner. However, the tested extract was able to inhibit 23.66% of the swarming and 35.25% of swimming capacities of PAO1 at 100 µg/mL. These results highlighted the role of germander as a potent antimicrobial agent that can interfere with the virulence factors controlled by the quorum-sensing systems.

          Related collections

          Most cited references98

          • Record: found
          • Abstract: found
          • Article: not found

          Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis

          The spread of antibiotic-resistant bacteria poses a substantial threat to morbidity and mortality worldwide. Due to its large public health and societal implications, multidrug-resistant tuberculosis has been long regarded by WHO as a global priority for investment in new drugs. In 2016, WHO was requested by member states to create a priority list of other antibiotic-resistant bacteria to support research and development of effective drugs.
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review

            The acronym ESKAPE includes six nosocomial pathogens that exhibit multidrug resistance and virulence: Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp. Persistent use of antibiotics has provoked the emergence of multidrug resistant (MDR) and extensively drug resistant (XDR) bacteria, which render even the most effective drugs ineffective. Extended spectrum β-lactamase (ESBL) and carbapenemase producing Gram negative bacteria have emerged as an important therapeutic challenge. Development of novel therapeutics to treat drug resistant infections, especially those caused by ESKAPE pathogens is the need of the hour. Alternative therapies such as use of antibiotics in combination or with adjuvants, bacteriophages, antimicrobial peptides, nanoparticles, and photodynamic light therapy are widely reported. Many reviews published till date describe these therapies with respect to the various agents used, their dosage details and mechanism of action against MDR pathogens but very few have focused specifically on ESKAPE. The objective of this review is to describe the alternative therapies reported to treat ESKAPE infections, their advantages and limitations, potential application in vivo, and status in clinical trials. The review further highlights the importance of a combinatorial approach, wherein two or more therapies are used in combination in order to overcome their individual limitations, additional studies on which are warranted, before translating them into clinical practice. These advances could possibly give an alternate solution or extend the lifetime of current antimicrobials.
              • Record: found
              • Abstract: found
              • Article: not found

              Natural products as sources of new drugs over the 30 years from 1981 to 2010.

              This review is an updated and expanded version of the three prior reviews that were published in this journal in 1997, 2003, and 2007. In the case of all approved therapeutic agents, the time frame has been extended to cover the 30 years from January 1, 1981, to December 31, 2010, for all diseases worldwide, and from 1950 (earliest so far identified) to December 2010 for all approved antitumor drugs worldwide. We have continued to utilize our secondary subdivision of a "natural product mimic" or "NM" to join the original primary divisions and have added a new designation, "natural product botanical" or "NB", to cover those botanical "defined mixtures" that have now been recognized as drug entities by the FDA and similar organizations. From the data presented, the utility of natural products as sources of novel structures, but not necessarily the final drug entity, is still alive and well. Thus, in the area of cancer, over the time frame from around the 1940s to date, of the 175 small molecules, 131, or 74.8%, are other than "S" (synthetic), with 85, or 48.6%, actually being either natural products or directly derived therefrom. In other areas, the influence of natural product structures is quite marked, with, as expected from prior information, the anti-infective area being dependent on natural products and their structures. Although combinatorial chemistry techniques have succeeded as methods of optimizing structures and have been used very successfully in the optimization of many recently approved agents, we are able to identify only one de novo combinatorial compound approved as a drug in this 30-year time frame. We wish to draw the attention of readers to the rapidly evolving recognition that a significant number of natural product drugs/leads are actually produced by microbes and/or microbial interactions with the "host from whence it was isolated", and therefore we consider that this area of natural product research should be expanded significantly.

                Author and article information

                Journal
                Plants (Basel)
                Plants (Basel)
                plants
                Plants
                MDPI
                2223-7747
                23 October 2020
                November 2020
                : 9
                : 11
                : 1418
                Affiliations
                [1 ]Department of Biology, University of Hail, College of Science, P.O. Box 2440, Ha’il 2440, Saudi Arabia; mo.alreshidi@ 123456uoh.edu.sa (M.A.); eb.noumi@ 123456uoh.edu.sa (E.N.); n.vajid@ 123456uoh.edu.sa (V.N.V.); mo.adnan@ 123456uoh.edu.sa (M.A.); s.elkahoui@ 123456uoh.edu.sa (S.E.); ri.badraoui@ 123456uoh.edu.sa (R.B.)
                [2 ]Laboratory of Bioressources, Integrative Biology and Recovery, High Institute of Biotechnology–University of Monastir, Monastir 5000, Tunisia
                [3 ]Laboratory of Bioactive Substances, Center of Biotechnology of Borj Cedria (CBBC), BP 901, Hammam Lif 2050, Tunisia; lamjed.bouslama@ 123456gmail.com
                [4 ]Ula Ali Kocman Vocational School, Mugla SitkiKocman University, Mugla 48147, Turkey; ozgceylan@ 123456hotmail.com
                [5 ]Department of Pharmacognosy, Faculty of Pharmacy, “Victor Babes” University of Medicine and Pharmacy, 2 Eftimie Murgu Square, Timisoara 300041, Romania; corina.danciu@ 123456umft.ro
                [6 ]Section of Histology—Cytology, Medicine College of Tunis, Tunis El Manar University, Road Djebel Lakhdhar, La Rabta-Tunis 1007, Tunisia
                [7 ]Laboratory of Histo-Embryology and Cytogenetic, Medicine College of Sfax, Sfax University, Sfax 3029, Tunisia
                [8 ]Molecular Diagnostic and Personalized Therapeutics Unit, University of Ha’il, Ha’il 2440, Saudi Arabia; mbkhm65@ 123456gmail.com
                [9 ]Bapalal Vaidya Botanical Research Centre, Department of Biosciences, Veer Narmad South Gujarat University, Surat, Gujarat 395007, India; patelmeet15@ 123456gmail.com
                [10 ]Department of Pharmacy, University of Salerno, Via Giovanni Paolo II, 132, Fisciano, 84084 Salerno, Italy; defeo@ 123456unisa.it
                [11 ]Laboratory of Genetics, Biodiversity and Valorisation of Bioresources, High Institute of Biotechnology–University of Monastir, Monastir 5000, Tunisia
                Author notes
                [* ]Correspondence: m.snoussi@ 123456uoh.edu.sa ; Tel.: +966-530-463-706
                Author information
                https://orcid.org/0000-0002-1865-1093
                https://orcid.org/0000-0002-7080-6822
                https://orcid.org/0000-0001-9054-7744
                https://orcid.org/0000-0002-9283-2124
                https://orcid.org/0000-0002-1070-3207
                https://orcid.org/0000-0002-2309-2601
                Article
                plants-09-01418
                10.3390/plants9111418
                7690738
                33114026
                12b72639-68c5-4e74-9939-ce48e2f5f0e4
                © 2020 by the authors.

                Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ( http://creativecommons.org/licenses/by/4.0/).

                History
                : 22 September 2020
                : 19 October 2020
                Categories
                Article

                teucrium polium l.,aerial parts,bioactive compounds,hr-lcms,biological activities

                Comments

                Comment on this article

                Related Documents Log